New drug made available outside clinical trials for patients in need
NCT ID NCT07647627
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This program allows certain patients to receive dibotatug (DR-01) even if they cannot join a clinical trial. It is only for those with a doctor's request and who meet specific criteria. The goal is to provide access to a potential treatment when no other options are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dibotatug (DR-01)
What this could lead to
If this program helps patients, it could provide early access to a potential treatment for those with no other options.
What could go wrong
This is an expanded access program, not a clinical trial, so there is no guarantee of benefit. Risks are not fully known and may include serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new related studies are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••